Immunosuppressive treatment in diffuse cutaneous systemic sclerosis is associated with an improved composite response index (CRISS)

Table 3 Balancing effect of the propensity scores between exposed and unexposed groups

	Standardized difference* between groups before IPTW	Standardized difference* between groups after IPTW
Age	0.44	0.04
Female sex	0.07	0.02
Disease duration	0.73	0.08
mRSS	0.20	0.06
FVC %predicted	0.15	0.05
HAQ	0.07	0.02
PTGA disease severity	0.13	0.05
PGA disease severity	0.80	0.02

IPTW inverse probability of treatment weighting, mRSS modified Rodnan skin score, FVC% percent of predicted forced vital capacity, HAQ Health Assessment Questionnaire, PTGA patient global assessment, PGA physician global assessment
*Standardized difference ≤ 0.1 represents meaningful balance

ISSN: 1478-6362